INZY - Inozyme Pharma GAAP EPS of -$0.38 beats by $0.02 May, 08 2024 03:54 AM Inozyme Pharma Inc. 2024-05-08 03:54:18 ET More on Inozyme Pharma Inozyme: Several Catalysts To Move Rare Disease Pipeline Programs Forward Seeking Alpha’s Quant Rating on Inozyme Pharma Historical earnings data for Inozyme Pharma Financial information for Inozyme Pharma For further details see: Inozyme Pharma GAAP EPS of -$0.38 beats by $0.02